Effects of astragaloside IV on the pharmacokinetics of puerarin in rats

Abstract Radix astragali and puerarin are always used together for cardiovascular disease in China clinics. This study investigates the effects of astragaloside IV (AS-IV, the main components of radix astragali) on the pharmacokinetics of puerarin in rats. The pharmacokinetics of orally administered puerarin (50 mg/kg) with or without AS-IV pretreatment (100 mg/kg/day for seven days) were investigated. The plasma concentration of puerarin was determined using LC–MS/MS method, and the pharmacokinetics profiles were calculated and compared. Caco-2 cell transwell model was also used to investigate the effects of AS-IV on the transport pf puerarin. The results showed that when the rats were pretreated with AS-IV, the maximum concentration (Cmax) of puerarin decreased from 760 to 467 ng/mL (p < .05, n = 6, 90% CI, 293 ± 61.28), and the area under the concentration-time curve from zero to infinity (AUC0–inf) also decreased from 4097 to 2330 μg·h/L (p < .05, n = 6). The oral clearance of puerarin increased significantly from 11.9 to 22.4 L/h/kg (p < .05, n = 6). The Caco-2 cell transwell experiments indicated that AS-IV could increase the efflux ratio of puerarin from 1.81 to 2.79 through inducing the activity of P-gp. In conclusion, these results indicated that AS-IV could affect the pharmacokinetics of puerarin, possibly by decreasing the systemic exposure of puerarin by inducing the activity of P-gp.

[1]  Hongqin Wang,et al.  Effects of glycyrrhizin on the pharmacokinetics of puerarin in rats , 2018, Xenobiotica; the fate of foreign compounds in biological systems.

[2]  Chang Liu,et al.  Puerarin Improves Vascular Insulin Resistance and Cardiovascular Remodeling in Salt-Sensitive Hypertension. , 2017, The American journal of Chinese medicine.

[3]  Shijun Wang,et al.  Effects of Radix Astragali and Its Split Components on Gene Expression Profiles Related to Water Metabolism in Rats with the Dampness Stagnancy due to Spleen Deficiency Syndrome , 2017, Evidence-based complementary and alternative medicine : eCAM.

[4]  Sang-Han Lee,et al.  Spatholobus suberectus Exhibits Antidiabetic Activity In Vitro and In Vivo through Activation of AKT-AMPK Pathway , 2017, Evidence-based complementary and alternative medicine : eCAM.

[5]  P. Anzenbacher,et al.  Interaction of isoflavonoids with human liver microsomal cytochromes P450: inhibition of CYP enzyme activities , 2017, Xenobiotica; the fate of foreign compounds in biological systems.

[6]  Zhiqiang Cheng,et al.  Radix Astragali-Based Chinese Herbal Medicine for Oxaliplatin-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis , 2016, Evidence-based complementary and alternative medicine : eCAM.

[7]  Yong-ming Yao,et al.  Astragaloside IV attenuates inflammatory reaction via activating immune function of regulatory T-cells inhibited by HMGB1 in mice , 2016, Pharmaceutical biology.

[8]  Zhongqiu Liu,et al.  Regulation of drug-metabolizing enzymes and efflux transporters by Astragali radix decoction and its main bioactive compounds: Implication for clinical drug-drug interactions. , 2016, Journal of ethnopharmacology.

[9]  Jisheng Xie,et al.  Anti-osteoporotic activity of puerarin 6″-O-xyloside on ovariectomized mice and its potential mechanism , 2016, Pharmaceutical biology.

[10]  Yun Luo,et al.  Mechanisms of improvement of intestinal transport of baicalin and puerarin by extracts of Radix Angelicae Dahuricae , 2015, Phytotherapy research : PTR.

[11]  Q. Meng,et al.  Pharmacokinetic interactions between herbal medicines and prescribed drugs: focus on drug metabolic enzymes and transporters. , 2015, Current drug metabolism.

[12]  Zheng-gen Liao,et al.  Transport Properties of Puerarin and Effect of Extract of Radix Angelicae dahuricae on Puerarin Intestinal Absorption Using In Situ and In Vitro Models , 2014, Phytotherapy research : PTR.

[13]  Cheng Peng,et al.  Puerarin: A Review of Pharmacological Effects , 2014, Phytotherapy research : PTR.

[14]  Xiao-yu Xu,et al.  Progress on the pharmacological research of puerarin: a review. , 2014, Chinese journal of natural medicines.

[15]  Z. Su,et al.  White Pepper and Piperine Have Different Effects on Pharmacokinetics of Puerarin in Rats , 2014, Evidence-based complementary and alternative medicine : eCAM.

[16]  S. Chong,et al.  In Vitro and In Vivo Evaluation of the Effect of Puerarin on Hepatic Cytochrome P450-Mediated Drug Metabolism , 2014, Planta Medica.

[17]  Yun Luo,et al.  Elucidation of the transport mechanism of baicalin and the influence of a Radix Angelicae Dahuricae extract on the absorption of baicalin in a Caco-2 cell monolayer model. , 2013, Journal of ethnopharmacology.

[18]  Z. Binkhathlan,et al.  P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives. , 2013, Current cancer drug targets.

[19]  Chan-Min Liu,et al.  Protective role of puerarin on lead-induced alterations of the hepatic glutathione antioxidant system and hyperlipidemia in rats. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[20]  Y. Masaoka,et al.  Estimation of P-glycoprotein-mediated efflux in the oral absorption of P-gp substrate drugs from simultaneous analysis of drug dissolution and permeation. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[21]  Tingzhong Wang,et al.  Puerarin: a novel antagonist to inward rectifier potassium channel (IK1) , 2011, Molecular and Cellular Biochemistry.

[22]  Wei-Dong Zhang,et al.  Preclinical pharmacokinetics and tissue distribution of a natural cardioprotective agent astragaloside IV in rats and dogs. , 2006, Life sciences.

[23]  Z. Hong,et al.  Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia , 2004, Neuroscience Letters.

[24]  P. Hufnagl,et al.  Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-κB activation and adhesion molecule expression , 2003, Thrombosis and Haemostasis.

[25]  G. Caldwell,et al.  Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery. , 2001, Current topics in medicinal chemistry.

[26]  G. Cantelli-forti,et al.  Comparison between chinese medical herb Pueraria lobata crude extract and its main isoflavone puerarin antioxidant properties and effects on rat liver CYP-catalysed drug metabolism. , 2000, Life sciences.

[27]  D. Roden,et al.  The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. , 1998, The Journal of clinical investigation.